Topo Biotechnology Co., Ltd.Plant Molecular Extraction

Low abundance and high activity plant trace components and

Industrial separation and extraction of monomer compounds

Low abundance and high activity plant trace components and

Industrial separation and extraction of monomer compounds

topo

Biotechnology

Topo Biotechnology Co., Ltd. has landed in Yuhang District, Hangzhou City, with large-scale production sites and standardized laboratories of 3000 square meters.
The company is committed to: plant low abundance high activity trace components and monomer compounds.
Development of industrial separation and extraction technology system and equipment.

Learn More

Corporate Vision

Establish the world's largest library of low-abundance and high-activity plant trace components and monomer compounds to solve the problem of lack of material base for botanical drug development that has plagued the world for decades.

Learn More

Products

Low-abundance trace component library

Currently in the library

Plant species:

152

Number of components:

3750

View Details>>

Industrial Development of Monomer Compounds

Learn More

Project Background Industry pain points Technical comparison Business Model

Our team

Learn More

Chen Ling

Doctor of Medicine Chief Scientist

Former head of the Respiratory Medicine Research Department at the Affiliated Hospital of Zunyi Medical University, led more than 40 projects including 3 National Natural Science Foundation grants and sub-tasks of the National Major Infectious Disease Science and Technology Project. Recipient of the National May 1st Women's Model Worker Award, National Advanced Individual for Returned Overseas Chinese and Their Relatives, Second Prize of the Guizhou Provincial Government Science and Technology Progress Award, and multiple honors such as the Harvard University Harvard Medical School - Dubai UAE "Global Scholar Award".

View Details

Fu Hongzheng

PharmD Chief Scientist

Engaged in natural drug chemistry and synthetic drug research at the State Key Laboratory of Natural and Biomimetic Drugs, Peking University, and conducted new drug development. Led multiple major new drug development projects. Developed several new drugs including Vincristine, Atorvastatin Calcium; Edaravone; Levofloxacin; Rhodiola Injection; Astragaloside Injection, among others, with 20 authorized invention patents. Member of the New Drug Review Committee of the National Medical Products Administration and the New Drug Fund Review Committee of the Ministry of Finance.

View Details

Xu Peng

PhD in Pathogen Biology Application Lead

Previously worked at Shenzhen National Center for Infectious Diseases Clinical Medicine Research, mainly engaged in clinical and drug resistance research of tuberculosis and mycobacteria, led the Shenzhen Natural Science Foundation Basic Research General Project, and served as a communication review expert for the National Natural Science Foundation Youth Fund. From June 2016 to July 2022, served as an associate professor, master's supervisor, and key discipline member at Zunyi Medical University, a high-level talent introduced by Guizhou Province, engaged in tuberculosis and mycobacterium tuberculosis related research.

View Details

Our team

Learn More

Chen Ling

Doctor of Medicine Chief Scientist

View Details

News

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

plant trace compounds
Industrialized Separation Research and Achievement Transformation

Address: Huayan Hangzhou Future Research Park, Yuhang District, Hangzhou City, Zhejiang Province (Dragon Boat Road)
Telephone:86-13929906655

E-mail：tp2019826@163.com

TOPO BIOTECHNOLOGY CO.,LTD. Powered by www.300.cn SEO

Business License

Please tell us your needs.

*Leave your contact information to get a free product quote